Bioavailability of Dexlansoprazole MR 60 mg When Administered via Oral Syringe or Nasogastric Tube
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Erosive oesophagitis; Gastro-oesophageal reflux
- Focus Pharmacokinetics
- 02 Jul 2013 New trial record
- 18 May 2013 Results presented at the Digestive Disease Week 2013.